DNA-Functionalized Ti3C2Tx MXenes for Selective and Rapid Detection of SARS-CoV-2 Nucleocapsid Gene
Source abstract
Abstract
Coronavirus disease 2019 (COVID-19) is an emerging human infectious disease caused by severe acute respiratory syndrome 2 (SARS-CoV-2, initially called novel coronavirus 2019-nCoV) virus. Thus, an accurate and specific diagnosis of COVID-19 is urgently needed for effective point-of-care detection and disease management. The reported promise of two-dimensional (2D) transition-metal carbides (Ti3C2Tx MXene) for biosensing owing to a very high surface area, high electrical conductivity, and hydrophilicity informed their selection for inclusion in functional electrodes for SARS-CoV-2 detection. Here, we demonstrate a new and facile functionalization strategy for Ti3C2Tx with probe DNA molecules through noncovalent adsorption, which eliminates expensive labeling steps and achieves sequence-specific recognition. The 2D Ti3C2Tx functionalized with complementary DNA probes shows a sensitive and selective detection of nucleocapsid (N) gene from SARS-CoV-2 through nucleic acid hybridization and chemoresistive transduction. The fabricated sensors are able to detect the SARS-CoV-2 N gene with sensitive and rapid response, a detection limit below 105 copies/mL in saliva, and high specificity when tested against SARS-CoV-1 and MERS. We hypothesize that the MXenes’ interlayer spacing can serve as molecular sieving channels for hosting organic molecules and ions, which is a key advantage to their use in biomolecular sensing.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: MXene and MAX Phase Materials · Advanced biosensing and bioanalysis techniques · Energy Harvesting in Wireless Networks
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Materials Engineering, Purdue University, West Lafayette, Indiana 47907, United States
Birck Nanotechnology Center, Purdue University, West Lafayette, Indiana 47907 United States
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana 47907 United States
Purdue Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907 United States
Funding
Division of Chemical, Bioengineering, Environmental, and Transport Systems
References (60)
Show source-provided references
1. Coronavirus disease 2019. COVID-19 Situation Report; World Health Organization, 2020.
2. 10.2807/1560-7917.ES.2020.25.3.200004510.2807/1560-7917.ES.2020.25.3.2000045 ↗
3. 10.2807/1560-7917.ES.2020.25.24.200105710.2807/1560-7917.ES.2020.25.24.2001057 ↗
4. 10.1021/acsnano.0c0262410.1021/acsnano.0c02624 ↗
5. 10.1021/acssensors.0c0118010.1021/acssensors.0c01180 ↗
6. 10.1021/acsnano.0c0243910.1021/acsnano.0c02439 ↗
7. 10.1021/acsnano.0c0282310.1021/acsnano.0c02823 ↗
8. 10.1021/acs.nanolett.1c0011810.1021/acs.nanolett.1c00118 ↗
9. 10.1021/jacs.0c1081010.1021/jacs.0c10810 ↗
10. 10.1016/j.bios.2020.11243610.1016/j.bios.2020.112436 ↗
11. 10.1002/adma.20140108410.1002/adma.201401084 ↗
12. 10.1021/acs.nanolett.8b0381810.1021/acs.nanolett.8b03818 ↗
13. 10.1021/acs.langmuir.6b0450210.1021/acs.langmuir.6b04502 ↗
14. 10.1002/adma.20110230610.1002/adma.201102306 ↗
15. 10.1038/natrevmats.2016.9810.1038/natrevmats.2016.98 ↗
16. 10.1021/acsnano.0c0548210.1021/acsnano.0c05482 ↗
17. 10.1039/C8CS00324F10.1039/C8CS00324F ↗
18. 10.1002/adfm.20180197210.1002/adfm.201801972 ↗
19. 10.1016/j.mattod.2019.05.01710.1016/j.mattod.2019.05.017 ↗
20. 10.1016/j.chempr.2018.08.03710.1016/j.chempr.2018.08.037 ↗
21. 10.1021/acsnano.9b0639410.1021/acsnano.9b06394 ↗
22. 10.1021/acs.analchem.8b0308310.1021/acs.analchem.8b03083 ↗
23. 10.1021/acs.analchem.1c0037110.1021/acs.analchem.1c00371 ↗
24. 10.1002/advs.20180051810.1002/advs.201800518 ↗
25. 10.1016/j.tibtech.2019.09.00110.1016/j.tibtech.2019.09.001 ↗
26. 10.1021/acsnano.0c0959510.1021/acsnano.0c09595 ↗
27. 10.1038/ncomms1490210.1038/ncomms14902 ↗
28. 10.1021/acsnano.7b0746010.1021/acsnano.7b07460 ↗
29. 10.1002/adfm.20090163910.1002/adfm.200901639 ↗
30. 10.1039/C9SC03049B10.1039/C9SC03049B ↗
31. 10.1002/nano.20200030910.1002/nano.202000309 ↗
32. 10.1021/acs.analchem.0c0078410.1021/acs.analchem.0c00784 ↗
33. 10.1016/j.bios.2019.11153110.1016/j.bios.2019.111531 ↗
34. 10.1021/acs.accounts.7b0048110.1021/acs.accounts.7b00481 ↗
35. 10.1038/s41467-017-02529-610.1038/s41467-017-02529-6 ↗
36. 10.1039/D1TA03070A10.1039/D1TA03070A ↗
37. 10.1039/C7TA11347A10.1039/C7TA11347A ↗
38. 10.1021/acs.chemmater.7b0284710.1021/acs.chemmater.7b02847 ↗
39. 10.1021/acsami.5b1197310.1021/acsami.5b11973 ↗
40. 10.1021/cm500641a10.1021/cm500641a ↗
41. 10.1039/C6CC07733A10.1039/C6CC07733A ↗
42. 10.1021/ja971958610.1021/ja9719586 ↗
43. 10.1016/S0140-6736(20)30251-810.1016/S0140-6736(20)30251-8 ↗
44. 10.1073/pnas.200313811710.1073/pnas.2003138117 ↗
45. Walls A. C. · Cell · 2020 · 181 · 28110.1016/j.cell.2020.02.058 ↗
46. 10.1016/j.cell.2020.06.04310.1016/j.cell.2020.06.043 ↗
47. 10.1128/JVI.00647-2010.1128/JVI.00647-20 ↗
48. 10.1126/science.108641810.1126/science.1086418 ↗
49. 10.1128/JVI.01925-1910.1128/JVI.01925-19 ↗
50. 10.1093/cid/ciaa138210.1093/cid/ciaa1382 ↗
51. 10.1001/jamainternmed.2020.887610.1001/jamainternmed.2020.8876 ↗
52. 10.1021/acssensors.9b0030310.1021/acssensors.9b00303 ↗
53. 10.1038/s41467-020-18611-510.1038/s41467-020-18611-5 ↗
54. 10.1021/acsnano.0c0442110.1021/acsnano.0c04421 ↗
55. 10.1021/acs.analchem.5b0159410.1021/acs.analchem.5b01594 ↗
56. 10.1056/NEJMc151169510.1056/NEJMc1511695 ↗
57. 10.1056/NEJMc200173710.1056/NEJMc2001737 ↗
58. 10.1016/j.jinf.2020.06.06710.1016/j.jinf.2020.06.067 ↗
59. Prevention, U. C. f.D. C. A., 2019-Novel Coronavirus (2019-nCoV) Real-time rRT-PCR Primers and Probes, 2020.
60. 10.1021/acsnano.0c0389610.1021/acsnano.0c03896 ↗